NDC 61133-0899 - Dexium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61133-0899
- Package NDCs from labels
- 61133-0899-9
- Manufacturer
- Bimeda, Inc. | Bimeda-MTC Animal Health
- Effective date
- 2024-04-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexium - Bimeda, Inc. | Bimeda-MTC Animal Health | Bimeda, Inc. | Bimeda-MTC Animal Health | 2024-04-23 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61133-0899-9 | Dexium | 100 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 100 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61133-0899 | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC.] | 9 | 1 package rows | 20240424_d6113f31-01d7-4e98-9c2c-33bd2ea82f42.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Dexamethasone | ACTIVE INGREDIENT | 7S5I7G3JQL | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 3 | |
| Dexamethasone | ACTIVE MOIETY | 7S5I7G3JQL | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 3 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | DEXIUM (DEXAMETHASONE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone 1.5 mg | DEXAMETHASONE 1.5 MG | Larken Laboratories, Inc. | fcc75691-974e-4a67-b9d7-64dde72b5595 | 2025-10-15 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Apotex Corp. | bfaa71cb-e517-8d94-f64b-8cdbf7b8fbf2 | 2025-09-17 | Warnings, Adverse reactions | 7S5I7G3JQL |
| dexamethasone | DEXAMETHASONE | Major Pharmaceuticals | 5ec5b0e6-7fa8-4afc-97a4-d185484ada8b | 2025-09-08 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Rising Pharma Holdings, Inc. | 7cf5c17c-a80b-4547-83b2-0d53e2b933f7 | 2025-09-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Preferred Pharmaceuticals, Inc. | 449a6fd8-c2ac-40d0-b74a-e5c7fc6670f3 | 2025-08-18 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | A-S Medication Solutions | 16c59e9a-8e4f-4300-bbbb-bcc982c18fc8 | 2025-08-15 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | A-S Medication Solutions | 89af5591-eebf-44e7-827f-ce3b123123e4 | 2025-08-15 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | 141e16a7-1f3d-3943-e063-6294a90ac5a9 | 2025-07-30 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone Intensol | DEXAMETHASONE INTENSOL | Hikma Pharmaceuticals USA, Inc. | b15200fb-1826-472b-a907-e677a272513b | 2025-06-06 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Insecticides/Pest/Food Additives Detox | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Dr. Donna Restivo DC | b5778211-0e3e-44ef-bd65-a76a68cf1504 | 2025-05-23 | Warnings | Z8IX2SC1OH |
| Dexamethasone | DEXAMETHASONE | Advanced Rx of Tennessee, LLC | 348f5a56-978d-4272-e063-6294a90afdb6 | 2025-05-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| MAXIDEX | DEXAMETHASONE | Harrow Eye, LLC | 35e47fcd-e020-43e5-8322-41f8060d220d | 2025-05-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | PD-Rx Pharmaceuticals, Inc. | a5609df4-4933-4f85-a7b8-bc54a70a2bac | 2025-04-30 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Marlex Pharmaceuticals, Inc | 7b51ffce-ec64-4b49-8870-b9666537c541 | 2025-04-22 | Warnings, Adverse reactions | 7S5I7G3JQL |
| DEXTENZA | DEXAMETHASONE | Ocular Therapeutix, Inc. | 7514e6b8-c33f-4fbf-8810-ef520e1eb4bd | 2025-04-18 | Warnings, Adverse reactions | 7S5I7G3JQL |
| NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE SUSPENSION/ DROPS | DirectRx | d5e00bad-abb4-63ad-e053-2a95a90a5abb | 2025-04-15 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Sandoz Inc | 05fd0c36-39b4-4a43-8490-eb8dfc0920ae | 2025-04-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobradex ST | TOBRAMYCIN / DEXAMETHASONE | Harrow Eye, LLC | 3b99dbb3-ac84-4d0d-b30f-a5db44fdc316 | 2025-04-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Proficient Rx LP | 3f2fe98a-ab42-4bec-bf97-c090567f9ad6 | 2025-04-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | Z8IX2SC1OH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.